IGC Pharma, Inc. SEC filings IGC
IGC Pharma, Inc. has 817 filings in SEC EDGAR's recent list, going back to May 13, 2005. Its latest annual report, Form 10-KT, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-KT | Transition report | Mar 18, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Jun 27, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Jun 24, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Jul 7, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Jun 23, 2022 | Mar 31, 2022 |
| 10-K | Annual report | Jun 14, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Jul 13, 2020 | Mar 31, 2020 |
| 10-K | Annual report | Jun 14, 2019 | Mar 31, 2019 |
| 10-K | Annual report | Jun 21, 2018 | Mar 31, 2018 |
| 10-K | Annual report | Jul 14, 2017 | Mar 31, 2017 |
| 10-K | Annual report | Jul 14, 2016 | Mar 31, 2016 |
| 10-K | Annual report | Jul 14, 2015 | Mar 31, 2015 |
| 10-K | Annual report | Jul 15, 2014 | Mar 31, 2014 |
| 10-K/A | Amended annual report | Jul 15, 2014 | Mar 31, 2013 |
| 10-K | Annual report | Jul 16, 2013 | Mar 31, 2013 |
| 10-K | Annual report | Jul 16, 2012 | Mar 31, 2012 |
| 10-K/A | Amended annual report | Nov 3, 2011 | Mar 31, 2011 |
| 10-K/A | Amended annual report | Jul 27, 2011 | Mar 31, 2011 |
| 10-K | Annual report | Jul 14, 2011 | Mar 31, 2011 |
| 10-K/A | Amended annual report | Jan 28, 2011 | Mar 31, 2010 |
| ARS | Annual report to shareholders | Jul 30, 2010 | Mar 31, 2010 |
| 10-K | Annual report | Jul 14, 2010 | Mar 31, 2010 |
| 10-K | Annual report | Jul 14, 2009 | Mar 31, 2009 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IGC (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- MD
- Headquarters
- Potomac, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1326205
- Former names
- India Globalization Capital, Inc. (until Mar 21, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.